Our analysis identified specific weaknesses that patients should consider when making treatment decisions
Patients Looking to Improve Metabolic Health : Those seeking to improve blood sugar regulation, insulin sensitivity, and reduce their risk of developing conditions like type 2 diabetes may find semaglutide beneficial
B-12 promotes normal growth and development of cells
For weight management , certain GLP-1 formulations (liraglutide 3.0mg [Saxenda] and semaglutide 2.4mg [Wegovy]) are licensed for chronic weight management in adults with: BMI 30 kg/m , or BMI 27 kg/m with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, or dyslipidaemia) However, NHS access to these medications for weight management is typically restricted to specialist tier 3 or tier 4 weight management services, with specific eligibility criteria defined by NICE technology appraisals (TA494 for liraglutide, TA664 for semaglutide) and local commissioning arrangements
Is there a money-back guarantee
Most patients pay out-of-pocket